Education
About Us
Working with TipRanks
Follow Us
AptarGroup (ATR)
NYSE:ATR
ATR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$130.85 - $178.03
Previous CloseN/A
Volume34.64K
Average Volume (3M)525.48K
Market Cap
$8.98B
Enterprise Value$11.47B
Total Cash (Recent Filing)$169.76M
Total Debt (Recent Filing)$1.14B
Price to Earnings (P/E)23.5
Beta0.62
Next Earnings
Oct 30, 2025EPS Estimate
1.56Next Dividend Ex-Date
Oct 23, 2025Dividend Yield1.32%
Share Statistics
EPS (TTM)1.66
Shares Outstanding65,880,520
10 Day Avg. Volume489,457
30 Day Avg. Volume525,478
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)4.22
Price to Sales (P/S)2.91
P/FCF Ratio29.84
Enterprise Value/Market Cap1.28
Enterprise Value/Revenue3.18
Enterprise Value/Gross Profit8.73
Enterprise Value/Ebitda14.18
Forecast
1Y Price Target
$179.75Price Target Upside31.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Market PositionATR is a global leader in Intranasal Drug Delivery Solutions with an estimated market share of over 90%.
Pharma Segment GrowthAptarGroup is evolving into a more pharma-centric packaging company, which has shown strong growth and now constitutes 45% of revenue and nearly 70% of EBITDA.
ProfitabilityAptarGroup has made impressive progress on profitability with 350 basis points of EBITDA margin expansion.
Bears Say
Headwinds In PharmaThe expectation for near-term headwinds in Pharma is anticipated to temporarily nullify its relative advantages compared to other packaging companies.
Inventory ChallengesHeadwinds include continued high inventories of cold/flu products in Europe and normalized sales growth of naloxone.
Legal ExpensesLegal expenses related to intellectual property litigation in Pharma are impacting third-quarter guidance.
AptarGroup News
ATR FAQ
What was AptarGroup’s price range in the past 12 months?
AptarGroup lowest stock price was $130.85 and its highest was $178.03 in the past 12 months.
What is AptarGroup’s market cap?
AptarGroup’s market cap is $8.98B.
When is AptarGroup’s upcoming earnings report date?
AptarGroup’s upcoming earnings report date is Oct 30, 2025 which is in 47 days.
How were AptarGroup’s earnings last quarter?
AptarGroup released its earnings results on Jul 31, 2025. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.588 by $0.072.
Is AptarGroup overvalued?
According to Wall Street analysts AptarGroup’s price is currently Undervalued.
Does AptarGroup pay dividends?
AptarGroup pays a Quarterly dividend of $0.48 which represents an annual dividend yield of 1.32%. See more information on AptarGroup dividends here
What is AptarGroup’s EPS estimate?
AptarGroup’s EPS estimate is 1.56.
How many shares outstanding does AptarGroup have?
AptarGroup has 65,880,520 shares outstanding.
What happened to AptarGroup’s price movement after its last earnings report?
AptarGroup reported an EPS of $1.66 in its last earnings report, beating expectations of $1.588. Following the earnings report the stock price went down -10.048%.
Which hedge fund is a major shareholder of AptarGroup?
Currently, no hedge funds are holding shares in ATR
AptarGroup Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$179.75 (31.11% Upside)
$179.75 (31.11% Upside)
Blogger Sentiment
Bullish
ATR Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 437.0 Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $466.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 6.7%
Last 30 Days ▼ 6.7%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.07%
12-Months-Change
Fundamentals
Return on Equity
15.36%
Trailing 12-Months
Asset Growth
9.25%
Trailing 12-Months
Company Description
AptarGroup
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
ATR Company Deck
ATR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a positive picture overall, with strong EPS growth and significant achievements in sustainability and segment performance. However, challenges persist in the Consumer Healthcare segment, Prestige Beauty, and due to increased legal expenses. The normalization of Naloxone sales also presents a potential hurdle.View all ATR earnings summariesATR Stock 12 Month Forecast
Average Price Target
$179.75
▲(31.11% Upside)
Technical Analysis
Baxter International
―
Cooper Co
―
Repligen
―
West Pharmaceutical Services
―
Stevanato Group
―
Ownership Overview
0.77% Insiders
33.14% Mutual Funds
25.49% Other Institutional Investors
16.45% Public Companies and
Individual Investors